MARKET

PPBT

PPBT

Purple Biotech Ltd
NASDAQ
1.795
-0.185
-9.34%
Opening 15:51 09/04 EDT
OPEN
2.020
PREV CLOSE
1.980
HIGH
2.095
LOW
1.730
VOLUME
303.10K
TURNOVER
--
52 WEEK HIGH
19.40
52 WEEK LOW
1.160
MARKET CAP
2.91M
P/E (TTM)
-0.0642
1D
5D
1M
3M
1Y
5Y
1D
3 Penny Stocks on Investors’ Radar after Big Moves, 9/03/26
TipRanks · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 2d ago
Crude Oil Moves Higher; US Factory Orders Rise In July
Benzinga · 2d ago
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
Benzinga · 2d ago
Why Is Purple Biotech Stock Gaining Wednesday?
Benzinga · 2d ago
Why Is Purple Biotech (PPBT) Stock 42% Up Today?
TipRanks · 2d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 2d ago
Purple Biotech Gains New U.S. Patent Allowance for CAPTN-3 Cancer Immunotherapy Platform
TipRanks · 2d ago
More
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Webull offers Purple Biotech Ltd - ADR stock information, including NASDAQ: PPBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PPBT stock methods without spending real money on the virtual paper trading platform.